144 related articles for article (PubMed ID: 6176541)
1. Detection of gamma interferon in the sera of patients with Behçet's disease.
Ohno S; Kato F; Matsuda H; Fujii N; Minagawa T
Infect Immun; 1982 Apr; 36(1):202-8. PubMed ID: 6176541
[TBL] [Abstract][Full Text] [Related]
2. [Studies on interferon in Behçet's disease].
Kato F
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):63-73. PubMed ID: 6404745
[TBL] [Abstract][Full Text] [Related]
3. Studies on spontaneous production of gamma-interferon in Behçet's disease.
Ohno S; Kato F; Matsuda H; Fujii N; Minagawa T
Ophthalmologica; 1982; 185(3):187-92. PubMed ID: 6813789
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling.
Lee MT; Hooper LC; Kump L; Hayashi K; Nussenblatt R; Hooks JJ; Detrick B
Clin Exp Immunol; 2007 Jan; 147(1):71-80. PubMed ID: 17177965
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease.
Fujii N; Minagawa T; Nakane A; Kato F; Ohno S
J Immunol; 1983 Apr; 130(4):1683-6. PubMed ID: 6403610
[TBL] [Abstract][Full Text] [Related]
6. Interferon activity and its characterization in the sera of patients with head and neck cancer.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Furumoto N; Hayashi Y; Takegawa Y
Cancer; 1984 Oct; 54(7):1239-51. PubMed ID: 6205740
[TBL] [Abstract][Full Text] [Related]
7. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
Kötter I; Eckstein AK; Stübiger N; Zierhut M
Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease.
Hamzaoui K; Ayed K; Slim A; Hamza M; Touraine J
Clin Exp Immunol; 1990 Jan; 79(1):28-34. PubMed ID: 2154346
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease.
Aridogan BC; Yildirim M; Baysal V; Inaloz HS; Baz K; Kaya S
J Dermatol; 2003 Aug; 30(8):602-7. PubMed ID: 12928529
[TBL] [Abstract][Full Text] [Related]
12. IL-17, IL-10, IL-6, and IFN-γ in Egyptian Behçet's disease: correlation with clinical manifestations.
Talaat RM; Sibaii H; Bassyouni IH; El-Wakkad A
Eur Cytokine Netw; 2019 Mar; 30(1):15-22. PubMed ID: 31122907
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome.
Bacon TH; Ozbakir F; Elms CA; Denman AM
Clin Exp Immunol; 1984 Sep; 57(3):541-7. PubMed ID: 6432387
[TBL] [Abstract][Full Text] [Related]
14. Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.
Sun M; Yang P; Yang Y; Ye J
Int Ophthalmol; 2018 Oct; 38(5):1947-1953. PubMed ID: 28780618
[TBL] [Abstract][Full Text] [Related]
15. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
16. Presence of circulating antibodies to a disease-specific antigen on cultured human dermal microvascular endothelial cells in patients with Behçet's disease.
Lee KH; Bang D; Choi ES; Chun WH; Lee ES; Lee S
Arch Dermatol Res; 1999; 291(7-8):374-81. PubMed ID: 10482005
[TBL] [Abstract][Full Text] [Related]
17. [Studies on immune interferon in Behçet's disease (author's transl)].
Kato F; Ohno S; Fujii N; Minagawa T
Nippon Ganka Gakkai Zasshi; 1981 Sep; 85(9):1412-9. PubMed ID: 6172968
[No Abstract] [Full Text] [Related]
18. Interferon activity and its characterization in the sera of patients with premalignant lesions arising in oral mucosa.
Urata M; Yoshida H; Yanagawa T; Yura Y; Furumoto N; Azuma M; Hayashi Y; Sato M
Int J Oral Maxillofac Surg; 1986 Apr; 15(2):134-47. PubMed ID: 2420904
[TBL] [Abstract][Full Text] [Related]
19. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
[TBL] [Abstract][Full Text] [Related]
20. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature.
Kötter I; Koch S; Vonthein R; Rückwaldt U; Amberger M; Günaydin I; Zierhut M; Stübiger N
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S20-6. PubMed ID: 16273760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
